Original Article
Composition of the microbiota in patients with growth hormone deficiency before and after treatment with growth hormone
Composición de la microbiota en pacientes con déficit de hormona de crecimiento antes y después de recibir tratamiento
Patricia García Navasa,
, María Yolanda Ruíz del Pradob, Pablo Villoslada Blancoc, Emma Recio Fernándezc, María Ruíz del Campoa, Patricia Pérez Matutec,d
Corresponding author
a Sección de Endocrinología Infantil, Servicio de Pediatría, Hospital San Pedro, Logroño, La Rioja, Spain
b Servicio de Pediatría, Hospital San Pedro, Logroño, La Rioja, Spain
c Unidad de Enfermedades Infecciosas, Microbiota y Metabolismo, Centro de Investigación Biomédica de La Rioja (CIBIR), Logroño, La Rioja, Spain
d Facultad de Ciencias de la Salud de la Universidad de La Rioja, Logroño, La Rioja, Spain
Read
1107
Timeswas read the article
332
Total PDF
775
Total HTML
Share statistics
array:24 [ "pii" => "S2341287924001431" "issn" => "23412879" "doi" => "10.1016/j.anpede.2024.05.004" "estado" => "S300" "fechaPublicacion" => "2024-06-01" "aid" => "3608" "copyright" => "Asociación Española de Pediatría" "copyrightAnyo" => "2024" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2024;100:404-11" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1695403324000717" "issn" => "16954033" "doi" => "10.1016/j.anpedi.2024.03.006" "estado" => "S300" "fechaPublicacion" => "2024-06-01" "aid" => "3608" "copyright" => "Asociación Española de Pediatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2024;100:404-11" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original</span>" "titulo" => "Composición de la microbiota en pacientes con déficit de hormona de crecimiento antes y después de recibir tratamiento" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:3 [ 0 => "es" 1 => "es" 2 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "404" "paginaFinal" => "411" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Composition of the microbiota in patients with growth hormone deficiency before and after treatment with growth hormone" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 1 "multimedia" => array:5 [ "identificador" => "fig0020" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 826 "Ancho" => 1333 "Tamanyo" => 169901 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Patricia García Navas, María Yolanda Ruíz del Prado, Pablo Villoslada Blanco, Emma Recio Fernández, María Ruíz del Campo, Patricia Pérez Matute" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Patricia" "apellidos" => "García Navas" ] 1 => array:2 [ "nombre" => "María Yolanda" "apellidos" => "Ruíz del Prado" ] 2 => array:2 [ "nombre" => "Pablo" "apellidos" => "Villoslada Blanco" ] 3 => array:2 [ "nombre" => "Emma" "apellidos" => "Recio Fernández" ] 4 => array:2 [ "nombre" => "María" "apellidos" => "Ruíz del Campo" ] 5 => array:2 [ "nombre" => "Patricia" "apellidos" => "Pérez Matute" ] ] ] ] "resumen" => array:1 [ 0 => array:3 [ "titulo" => "Graphical abstract" "clase" => "graphical" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0020"></elsevierMultimedia></p></span>" ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2341287924001431" "doi" => "10.1016/j.anpede.2024.05.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287924001431?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403324000717?idApp=UINPBA00005H" "url" => "/16954033/0000010000000006/v3_202407150459/S1695403324000717/v3_202407150459/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2341287924001479" "issn" => "23412879" "doi" => "10.1016/j.anpede.2024.05.008" "estado" => "S300" "fechaPublicacion" => "2024-06-01" "aid" => "3613" "copyright" => "Asociación Española de Pediatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2024;100:412-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Quality assessment of clinical practice guidelines on hypoxic-ischaemic encephalopathy in newborns using the AGREE II tool: a systematic review" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:3 [ 0 => "en" 1 => "en" 2 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "412" "paginaFinal" => "419" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Evaluación de la calidad de las guías de práctica clínica sobre encefalopatía hipóxico isquémica en recién nacidos entre los años 2013 a 2022 mediante la herramienta AGREE II: una revisión de alcance" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 1 "multimedia" => array:5 [ "identificador" => "fig0015" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 826 "Ancho" => 1333 "Tamanyo" => 138336 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ana Arellano Haro, Ashley Cuzco Macías" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Ana" "apellidos" => "Arellano Haro" ] 1 => array:2 [ "nombre" => "Ashley" "apellidos" => "Cuzco Macías" ] ] ] ] "resumen" => array:1 [ 0 => array:3 [ "titulo" => "Graphical abstract" "clase" => "graphical" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0015"></elsevierMultimedia></p></span>" ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403324000766" "doi" => "10.1016/j.anpedi.2024.04.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403324000766?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287924001479?idApp=UINPBA00005H" "url" => "/23412879/0000010000000006/v2_202407150516/S2341287924001479/v2_202407150516/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2341287924001595" "issn" => "23412879" "doi" => "10.1016/j.anpede.2024.05.011" "estado" => "S300" "fechaPublicacion" => "2024-06-01" "aid" => "3626" "copyright" => "Asociación Española de Pediatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "An Pediatr (Barc). 2024;100:401-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Moving forward and making changes to gain perspective and keep improving" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "401" "paginaFinal" => "403" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Continuar y cambiar, para ganar perspectiva y seguir mejorando" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 188 "Ancho" => 605 "Tamanyo" => 20474 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Logo of the AEP.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Luis Carlos Blesa Baviera" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Luis Carlos" "apellidos" => "Blesa Baviera" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403324000961" "doi" => "10.1016/j.anpedi.2024.05.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403324000961?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287924001595?idApp=UINPBA00005H" "url" => "/23412879/0000010000000006/v2_202407150516/S2341287924001595/v2_202407150516/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Composition of the microbiota in patients with growth hormone deficiency before and after treatment with growth hormone" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "404" "paginaFinal" => "411" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Patricia García Navas, María Yolanda Ruíz del Prado, Pablo Villoslada Blanco, Emma Recio Fernández, María Ruíz del Campo, Patricia Pérez Matute" "autores" => array:6 [ 0 => array:4 [ "nombre" => "Patricia" "apellidos" => "García Navas" "email" => array:1 [ 0 => "pgnavas@riojasalud.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "María Yolanda" "apellidos" => "Ruíz del Prado" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Pablo" "apellidos" => "Villoslada Blanco" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Emma" "apellidos" => "Recio Fernández" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 4 => array:3 [ "nombre" => "María" "apellidos" => "Ruíz del Campo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 5 => array:3 [ "nombre" => "Patricia" "apellidos" => "Pérez Matute" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Sección de Endocrinología Infantil, Servicio de Pediatría, Hospital San Pedro, Logroño, La Rioja, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Pediatría, Hospital San Pedro, Logroño, La Rioja, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Unidad de Enfermedades Infecciosas, Microbiota y Metabolismo, Centro de Investigación Biomédica de La Rioja (CIBIR), Logroño, La Rioja, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Facultad de Ciencias de la Salud de la Universidad de La Rioja, Logroño, La Rioja, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Composición de la microbiota en pacientes con déficit de hormona de crecimiento antes y después de recibir tratamiento" ] ] "resumenGrafico" => array:2 [ "original" => 1 "multimedia" => array:5 [ "identificador" => "fig0020" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 826 "Ancho" => 1333 "Tamanyo" => 183365 ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Microbiota is defined as the community of microorganisms living in a specific environment. Generally, commensal microorganisms live in every epithelial surface of the body. The ratio of bacteria to human cells in the body is 1.3 to 1, and the total weight of these bacteria ranges from 0.2 to 0.4 kg. The microbiota could be considered the last organ of the human body, so that the latter could be considered a metaorganism or superorganism encompassing its (own) cells and all the microbes inhabiting the body.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> The term “microbiota” is used nearly exclusively to refer to the bacterial component and its chiefly composed by 4 bacterial phyla: Firmicutes, Bacteroidetes, Proteobacteria and Actinobacteria.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The establishment of the microbiota is a lifelong dynamic process.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3–5</span></a> It is influenced by factors such as the type of delivery, perinatal antimicrobial exposure or the infant feeding modality.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> Later in life, the composition and functioning of the microbiota is not set and can be affected by diet, antimicrobial use and other events (puberty, pregnancy, menopause).<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7,8</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Complex microbial ecosystems can be found in different regions of the body. The most populous and complex is the gut microbiota, especially in the ileum and colon, where the bacterial component has adapted to life in the intestinal lumen. These communities have a symbiotic and mutualistic interaction with human eukaryotic cells and are necessary for the correct functioning of the human organism. Changes in the composition or functioning of the microbiota (dysbiosis) have been associated with various diseases.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9,10</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Among the different functions performed by the microbiota, we ought to highlight its role in growth.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> Indeed, several studies have demonstrated that germ-free mice, lacking a gut microbiota, have decreased levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3) and exhibit growth restriction, with a decrease in linear growth and weight gain, which suggests that mammals need the gut microbiota to achieve optimal growth.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">12–14</span></a> In this regard, clinical studies in animal models have demonstrated that physiological levels of growth hormone (GH) maintain the integrity of the gut and improve gastrointestinal functioning. This effect of GH happens synergistically with IGF-1, as exemplified in bone growth, metabolism, and intestinal homeostasis,<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">15–18</span></a> indicating a potential relationship between GH/IGF-1 and the gut microbiota.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Somatostatin is secreted by the hypothalamus and inhibits GH in addition to preventing gastric acid secretion and slowing gut motility. Studies in mice models of congenital diarrhoeal disorders have found that these mice had increased levels of somatostatin and decreased gut hormone levels in addition to dysbiosis of the gut microbiota, which again points at the potential association between the gut microbiota and the GH/IGF-1 axis, although further research on the subject is still required.<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">15,19</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">The prevalence of GH deficiency in the paediatric population is of at least 1 in 3480 children, and the disorder can be isolated or associated to other pituitary hormone deficiencies. Clinically, it is characterised by proportionate postnatal growth. Affected individuals exhibit a reduced response to stimulation tests and decreased IGF-1 and IGFBP-3 levels. The indicated treatment is replacement with recombinant human GH.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a> In this context, and taking into account the laboratory characteristics of these patients, with decreased levels of GH and IGF-1, we conducted a study with the aim of determining whether these abnormalities were associated with changes in intestinal physiology/integrity and the composition of the gut microbiota.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Material and methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Study design</span><p id="par0035" class="elsevierStylePara elsevierViewall">Single centre case-control study including a total of 42 participants aged 4 to 14 years (21 cases and 20 controls). Cases underwent longitudinal follow-up to compare the gut microbiota and assess bacterial translocation before and after 6 months of treatment with GH.</p><p id="par0040" class="elsevierStylePara elsevierViewall">We recruited cases from the paediatric endocrinology clinic of a tertiary care hospital (May 2020–June 2022) right before the start of GH replacement therapy. The sample included those patients who met the diagnostic criteria for GH deficiency: clinical growth retardation and decreased response in 2 GH stimulus tests (GH < 7 ng/mL).<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">The controls were patients matched for age and sex. We included children who were scheduled to undergo a blood draw in the preoperative assessment before undergoing trauma, urological or ear, nose, throat surgery.</p><p id="par0050" class="elsevierStylePara elsevierViewall">We excluded patients with infectious or autoimmune disease, malabsorption syndrome, obesity or short stature in absence of GH deficiency. Patients who had been treated with antibiotics, probiotics or immunosuppressants in the past 3 months were also excluded.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">The study was approved by the regional Ethics Committee for Research with Medicines (file no.PI-399). We obtained informed consent from the parents or legal guardians of the patients.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Biochemical variables</span><p id="par0060" class="elsevierStylePara elsevierViewall">We measured levels of glucose, total cholesterol, high-density lipoprotein (HDL), low density lipoprotein (LDL) and triglycerides (c702 module, Cobas 8000 analyser series, Roche Diagnostics), insulin by electrochemiluminescence (e802 unit, Cobas 8000 analyser series, Roche Diagnostics), glycated haemoglobin (HbA1c) (Bio-Rad D100 analyser) and IGF-1 and IGFBP-3 by chemiluminescence (Immulite 2000, Siemens).</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Bacterial translocation</span><p id="par0065" class="elsevierStylePara elsevierViewall">We measured the serum levels of soluble cluster soluble of differentiation 14 (sCD14) and lipopolysaccharide binding protein (LBP) by means of Luminex technology, a type of immunoassay that can obtain accurate measurements in multiple simultaneous assays in a single sample. The Luminex xMAP technology is a bead-based multiplexed immunoassay system allowed the detection of up to 100 targets simultaneously, similar to what had been done in previous studies by our group.<a class="elsevierStyleCrossRefs" href="#bib0110"><span class="elsevierStyleSup">22,23</span></a></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">DNA extraction, 16S rRNA sequencing and bioinformatic analysis</span><p id="par0070" class="elsevierStylePara elsevierViewall">Participants collected faecal samples in a sterile container following the printed instructions provided by the research team, and the samples were aliquoted and stored at −80 °C for subsequent analysis. Then, the faecal samples were thawed and faecal DNA extracted using the Real Microbiome Fecal DNA kit (Durviz, Valencia, Spain) following the directions of the manufacturer. The purity, concentration and quality of the obtained DNA were assessed with a NanoDrop 1000 spectrophotometer (Thermo Scientific, USA), a Qubit 3.0 fluorometer (Thermo Fisher Scientific, MA, USA) and a fragment analyser (Agilent, USA).</p><p id="par0075" class="elsevierStylePara elsevierViewall">The samples were subjected to amplification of the V3-V4 hypervariable regions of the bacterial 16S rRNA gene. Amplicon sequencing was carried out with an Illumina system (MiSeq, 2 × 300 bp, paired-end) in the genomics and bioinformatics platform of the biomedical research centre. The first step thereafter was to assess the quality of the reads by means of the FastQC programme.<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a> Then we used the Qiime2 plugin<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">25</span></a> for the bioinformatic analysis. We started by denoising demultiplexed (by sample, based on barcoding) raw read files using the software DADA2.<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">26</span></a> This step included trimming of adaptor sequences and primers, filtering of low-quality reads, sequence dereplication to reduce repetition, merging of paired-end reads, the reconstruction of amplicon sequence variants (ASVs) and the removal of chimeras. Secondly, we used the SILVA database<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">27</span></a> trained with the primers used for amplification of the V3-V4 regions for taxonomic assignment. The next step was analysing α and β diversity: α diversity is a measure of the diversity of species in a given sample, while β diversity is a measures of the similarities between microbial communities in different samples, facilitating the identification of differences between them. We assessed α diversity with the following metrics: observed features, Chao1 index and Fisher α, indicators of species richness, the Pielou index of species evenness and the Shannon index and Simpson index of species diversity (richness + evenness). We assessed β-diversity by means of permutational ANOVA (PERMANOVA) (999 permutations) with Bray Curtis distances and visualised the results by means of principal coordinate analysis (PCoA) using the R Studio software (version 1.4.1105). Last of all, we analysed differential abundance with the ANCOM methodology<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">28</span></a> at the phylum, order and genus levels. This methodology is based on the underlying data structure and is widely used to compare microbiome composition in 2 or more populations without assumptions regarding the distribution of the population.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Statistical analysis</span><p id="par0080" class="elsevierStylePara elsevierViewall">The statistical analysis was carried out with the software SPSS version 22 (SPSS Inc. Chicago, IL, USA) and Prism 8 (GraphPad Prism, La Jolla, California, USA), defining statistical significance as a <span class="elsevierStyleItalic">P</span> value of less than 0.05.</p><p id="par0085" class="elsevierStylePara elsevierViewall">We used the Shapiro-Wilk test to assess the normality of distributions.</p><p id="par0090" class="elsevierStylePara elsevierViewall">To compare 2 groups, we used the independent samples <span class="elsevierStyleItalic">t</span> test or the Mann-Whitney <span class="elsevierStyleItalic">U</span> test based on whether the data followed a normal distribution. In the case of longitudinal analyses, we compared the data by means of the paired sample <span class="elsevierStyleItalic">t</span> test or the Wilcoxon test based on whether they followed a normal distribution.</p><p id="par0095" class="elsevierStylePara elsevierViewall">To compare qualitative variables, we used the χ<span class="elsevierStyleSup">2</span> test or, if the conditions required for it were not met, the Fisher exact test. We compared the three groups by means of analysis of variance (ANOVA) followed by the post hoc Tukey test.</p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Results</span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Demographic, biochemical and metabolic characteristics of cases compared to controls and to cases after treatment with growth hormone</span><p id="par0100" class="elsevierStylePara elsevierViewall">The mean age was 1 year younger in controls compared to cases (8.08 vs 9.11 years). As regards pubertal development, only 10% of controls had undergone onset of puberty compared to 28.6% of cases, although the difference was not statistically significant. None of the cases had GH deficiency secondary to another disease or GH deficiency combined with other pituitary hormone deficiencies.</p><p id="par0105" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> compares the control group, the case group at baseline and the case group at 6 months of treatment. As expected, we found a lower height in cases and improvement in height after treatment with GH (<span class="elsevierStyleItalic">P</span> < .01). We did not find changes in weight, although there was a reduction in the body mass index (BMI) <span class="elsevierStyleItalic">z</span> score with a <span class="elsevierStyleItalic">P</span> value that neared, but did not reach, statistical significance (<span class="elsevierStyleItalic">P</span> = .054).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0110" class="elsevierStylePara elsevierViewall">We found a statistically significant difference in IGF-1 levels between cases and controls and an increase in serum IGF-1 levels in cases after initiating treatment, as expected. We also found an increasing trend in IGFBP-3 values after treatment, although the difference was not statistically significant.</p><p id="par0115" class="elsevierStylePara elsevierViewall">After initiating treatment with GH, the only significant change observed in glucose metabolism was the serum glucose level (<span class="elsevierStyleItalic">P</span> < .01), with no changes in insulin or HbA1c levels or in the HOMA insulin resistance index.</p><p id="par0120" class="elsevierStylePara elsevierViewall">As regards lipid metabolism, we found a significant reduction in total cholesterol and LDL levels after treatment with GH (<span class="elsevierStyleItalic">P</span> < .01 and <span class="elsevierStyleItalic">P</span> < .05, respectively). On the other hand, there was also an increase in serum triglyceride levels (<span class="elsevierStyleItalic">P</span> < .01) after treatment.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Bacterial translocation</span><p id="par0125" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a> presents the results of the analysis of bacterial translocation.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0130" class="elsevierStylePara elsevierViewall">We found an increase in sCD14 levels compared to controls (<span class="elsevierStyleItalic">P</span> < .01) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A). Treatment with GH achieved recovery of these levels (<span class="elsevierStyleItalic">P</span> < .05). The pattern was very similar when we analysed the levels of LBP, although in this case the differences were not statistically significant (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>B).</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Alpha diversity of the gut bacteriome</span><p id="par0135" class="elsevierStylePara elsevierViewall">We compared cases and controls before and after treatment. We did not find statistically significant differences between the groups in any of the analysed indices, although in the case group values tended to be lower and exhibited an increasing trend after 6 months of GH replacement therapy (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>).</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Beta-diversity of the gut bacteriome</span><p id="par0140" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a> presents the principal coordinate analysis of the comparison of bacterial communities in the different groups under study. We did not find statistically significant differences between groups.</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Composition of the gut microbiota</span><p id="par0145" class="elsevierStylePara elsevierViewall">As regards relative abundance, we did not find statistically significant differences in bacterial taxa between the 3 groups under study, overall or at the phylum, genus or species level.</p></span></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Discussion</span><p id="par0150" class="elsevierStylePara elsevierViewall">Our study is the first to describe the composition of the gut microbiota in children with GH deficiency compared to healthy controls as well as changes in the composition of the gut microbiota after 6 months of GH replacement therapy.</p><p id="par0155" class="elsevierStylePara elsevierViewall">Glucose levels had increased significantly after treatment with GH. This hormone increases insulin sensitivity through the improvement of body composition on account of an increase in lean mass and a reduction in fat mass. However, it also stimulates glycogenolysis, gluconeogenesis and lipolysis, thereby increasing serum glucose levels. This has been previously studied in patients with GH deficiency in whom treatment was discontinued, who exhibited a decrease in glucose levels that then increased again once treatment resumed.<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a> In fact, a review of studies on the metabolic changes caused by treatment with GH found an initial worsening in glucose metabolism due to a reduction of insulin sensitivity followed by improvement over the long term due to the beneficial effects of treatment on body composition, which counteract the insulin-antagonist effect of GH, resulting in an overall increase in insulin sensitivity.<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">30</span></a></p><p id="par0160" class="elsevierStylePara elsevierViewall">Our study also found changes in the lipid profile after 6 months of treatment with GH, as children exhibited a significant decrease in total cholesterol and LDL levels, in agreement with the previous literature,<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a> since GH promotes the use of fat as a source of energy and therefore a reduction in adiposity and an increase in lean mass. On the other hand, we did not observe changes in HDL levels, which was also consistent with other studies, a finding that may be attributed, at least in part, to the short duration of follow-up after treatment initiation.<a class="elsevierStyleCrossRefs" href="#bib0155"><span class="elsevierStyleSup">31,32</span></a></p><p id="par0165" class="elsevierStylePara elsevierViewall">The increase in bacterial translocation observed in children with GH deficiency is of great interest, as it suggests an increase in gut permeability and therefore in the passage of microorganisms or parts thereof to the bloodstream, which in turn can trigger an inflammatory cascade in different tissues, with a negative impact on the health of the individual, since increased bacterial translocation is associated with chronic inflammation and increased cardiovascular risk.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> This increase in bacterial translocation could be related to the low levels of IGF-1 observed in these children, as demonstrated in a previous study.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">33</span></a></p><p id="par0170" class="elsevierStylePara elsevierViewall">Previous studies have also found that the IGF-1 receptor (IGF1R), through which IGF-1 carries out its functions, can modulate gut barrier function.<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">34</span></a> In this regard, our study showed that treatment with GH was associated with a significant increase in IGF-1 and IGFBP-3, similar to the increases reported in previous studies,<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">35</span></a> accompanied by a decrease in bacterial translocation,<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">18,36</span></a> which highlights the bidirectional association between IGF-1 and gut/microbiota function.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a></p><p id="par0175" class="elsevierStylePara elsevierViewall">However, these changes in bacterial translocation were not associated with changes in the composition of the microbiota. In fact, our study did not evince differences in the composition of the bacteriome between healthy children (controls) and children with GH deficiency, despite the detection of statistically significant differences in IGF-1 levels between the two groups. Treatment with GH increased these levels, as expected, but this increase was not associated with changes in the gut microbiota in terms of alpha or beta diversity or differential abundance. A possible explanation is that the increase in IGF-1 levels is not large enough to result in changes at the level of the microbiota or that a longer duration of follow-up is required for these changes to be detectable. In fact, studies in mice have found that the microbiota is more immature in those without GH, with lesser diversity at the genus level and reduced levels of bacteria of the Proteobacteria, Campylobacteria and Actinobacteria phyla.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">12,14,37–39</span></a> We may have failed to detect differences in our study due to the participation of patients who did not have total GH deficiency (GH < 3 ng/mL after 2 stimulation tests),<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a> as most participants had partial GH deficiency. In fact, a study that analysed the characteristics of the microbiota in patients with GH-secreting pituitary adenoma<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">40</span></a> found changes in the microbiota, with a decreased microbial diversity in patients with excess GH and statistically significant changes in both α and β diversity. In fact, the authors reported a change by more than 400 ng/mL in the IGF-1 level of patients when comparing preoperative and postoperative levels. In our study, the changes observed in patients after treatment, despite being statistically significant, did not reach 100 ng/mL in magnitude, which could also explain, at least in part, the absence of changes in composition in the microbiota of our patients.</p><p id="par0180" class="elsevierStylePara elsevierViewall">The main limitations of our study are the small size of each of the groups in the sample, the inclusion of patients with partial GH deficiency and the short follow-up duration of 6 months. A larger sample would allow a stratified analysis by age or pubertal stage. Further studies are required in larger samples and with a longer duration of treatment and longer duration of follow-up to assess changes in patients after discontinuation of GH treatment.</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">Conclusion</span><p id="par0185" class="elsevierStylePara elsevierViewall">Our study is the first to demonstrate that GH deficiency (growth retardation and decreased response [<7 ng/mL] in 2 GH stimulation tests) in children is not associated with changes in the gut microbiota compared to the microbiota of healthy children and that the gut microbiota of children treated with GH for 6 months also does change compared to baseline. However, growth retardation and decreased levels of IGF-1 and GH were associated with increased bacterial translocation, which was reversed with treatment, underscoring the beneficial effects of GH and IGF-1 not just on growth but also on intestinal integrity and, by extension, of all the axes associated with it: gut-brain axis, gut-liver axis, etc. However, more studies are required (with long durations of treatment or in patients with more severe GH deficiency) to understand in detail the association between GH/IGF-1 and the gut and its impact on child health, both in the short and the long term.</p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0145">Funding</span><p id="par0190" class="elsevierStylePara elsevierViewall">This study was funded by the <span class="elsevierStyleGrantSponsor" id="gs0005">Instituto de Estudios Riojanos</span> (IER) through grants for scientific research concerning La Rioja.</p></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0150">Conflicts of interest</span><p id="par0195" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:13 [ 0 => array:3 [ "identificador" => "xres2202330" "titulo" => "Graphical abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:3 [ "identificador" => "xres2202332" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0010" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0015" "titulo" => "Materials and methods" ] 2 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusions" ] ] ] 2 => array:2 [ "identificador" => "xpalclavsec1848197" "titulo" => "Keywords" ] 3 => array:3 [ "identificador" => "xres2202331" "titulo" => "Resumen" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Material y métodos" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Conclusiones" ] ] ] 4 => array:2 [ "identificador" => "xpalclavsec1848198" "titulo" => "Palabras clave" ] 5 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 6 => array:3 [ "identificador" => "sec0010" "titulo" => "Material and methods" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Study design" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Biochemical variables" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Bacterial translocation" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "DNA extraction, 16S rRNA sequencing and bioinformatic analysis" ] 4 => array:2 [ "identificador" => "sec0035" "titulo" => "Statistical analysis" ] ] ] 7 => array:3 [ "identificador" => "sec0040" "titulo" => "Results" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0045" "titulo" => "Demographic, biochemical and metabolic characteristics of cases compared to controls and to cases after treatment with growth hormone" ] 1 => array:2 [ "identificador" => "sec0050" "titulo" => "Bacterial translocation" ] 2 => array:2 [ "identificador" => "sec0055" "titulo" => "Alpha diversity of the gut bacteriome" ] 3 => array:2 [ "identificador" => "sec0060" "titulo" => "Beta-diversity of the gut bacteriome" ] 4 => array:2 [ "identificador" => "sec0065" "titulo" => "Composition of the gut microbiota" ] ] ] 8 => array:2 [ "identificador" => "sec0070" "titulo" => "Discussion" ] 9 => array:2 [ "identificador" => "sec0075" "titulo" => "Conclusion" ] 10 => array:2 [ "identificador" => "sec0080" "titulo" => "Funding" ] 11 => array:2 [ "identificador" => "sec0085" "titulo" => "Conflicts of interest" ] 12 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2023-12-05" "fechaAceptado" => "2024-03-25" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1848197" "palabras" => array:5 [ 0 => "Microbiota" 1 => "Growth" 2 => "Growth hormone deficiency" 3 => "Bacterial translocation" 4 => "Insulin-like growth factor 1 (IGF-1)" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1848198" "palabras" => array:4 [ 0 => "Microbiota" 1 => "Déficit de hormona de crecimiento" 2 => "Translocación bacteriana" 3 => "Factor de crecimiento similar a la insulina tipo 1 (IGF-1)" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Introduction</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Growth hormone (GH) and insulin-like growth factor-1 (IGF-1) have modulatory effects on bowel function and its microbiota. Our aim was to investigate whether low levels of GH and IGF-1 in patients with GH deficiency are associated with changes in gut physiology/integrity as well as in the composition of the gut microbiota.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Materials and methods</span><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">We conducted a case-control study in 21 patients with GH deficiency, at baseline and after 6 months of GH treatment, and in 20 healthy controls. We analysed changes in anthropometric and laboratory characteristics and bacterial translocation and studied the composition of the microbiome by means of massive 16S rRNA gene sequencing.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Growth hormone deficiency was accompanied by a significant increase in serum levels of sCD14, a marker of bacterial translocation (<span class="elsevierStyleItalic">P</span> < .01). This increase was reversed by GH treatment. We did not find any differences in the composition or α- or β-diversity of the gut microbiota after treatment or between cases and controls.</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusions</span><p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Our work is the first to demonstrate that the presence of GH deficiency is not associated with differences in gut microbiota composition in comparison with healthy controls, and changes in microbiota composition are also not found after 6 months of treatment. However, GH deficiency and low IGF-1 levels were associated with an increase in bacterial translocation, which had reversed after treatment.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0010" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0015" "titulo" => "Materials and methods" ] 2 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Introducción</span><p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">La hormona de crecimiento (GH) y el factor de crecimiento similar a la insulina tipo 1 (IGF-1) tienen efecto modulador sobre la funcionalidad intestinal y la microbiota. Nuestro objetivo fue investigar si pacientes con déficit de GH y por lo tanto niveles bajos de GH e IGF-1 se asocian con cambios en la fisiología/integridad intestinal así como en la composición de la microbiota intestinal.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Material y métodos</span><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Se realizó un estudio de casos y controles en 21 pacientes con déficit de GH previo al inicio y tras 6 meses de tratamiento con GH y en 20 controles sanos. Se estudiaron los cambios antropométricos, analíticos, de translocación bacteriana y también se determinó la composición del microbioma mediante secuenciación masiva del gen del ARNr 16S.</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Resultados</span><p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">El déficit de GH se acompañó de un incremento significativo en los niveles séricos de sCD14, un marcador de translocación bacteriana (p < 0.01). Dicho incremento fue revertido por el tratamiento con GH. No se observaron diferencias en la composición, ni en α o la β-diversidad de la microbiota intestinal entre los casos y los controles, ni tras recibir tratamiento.</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Conclusiones</span><p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">Nuestro trabajo demuestra por primera vez que un déficit de GH no se acompaña de cambios en la composición de la microbiota intestinal en comparación con controles sanos, ni tampoco se ve modificada tras 6 meses de tratamiento. Sin embargo, este déficit de GH y niveles bajos de IGF-1 si se asoció con un incremento en la traslocación bacteriana, que se vio revertido tras el tratamiento.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Material y métodos" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Conclusiones" ] ] ] ] "multimedia" => array:5 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 751 "Ancho" => 2341 "Tamanyo" => 97311 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Levels of bacterial translocation (A: sCD14 and B: LBP) in the paediatric sample under study. **<span class="elsevierStyleItalic">P</span> < .01 cases vs control and #<span class="elsevierStyleItalic">P</span> < .05 cases, baseline vs after treatment with growth hormone.</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">LBP, lipopolysaccharide binding protein; sCD14, soluble cluster soluble of differentiation 14.</p>" ] ] 1 => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2536 "Ancho" => 3008 "Tamanyo" => 246108 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Indices of α diversity in the bacteria present in stool samples of participants.</p>" ] ] 2 => array:8 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 2029 "Ancho" => 1675 "Tamanyo" => 191145 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Principal component analysis of bacterial communities in stool samples of participants (15% of total variance [component 1 = 8% and component 2 = 7%]). Results are presented according to the 2 principal components. Each dot represents a sample: red dots represent controls, green dots represent cases and blue dots cases after treatment. The grouping of samples is represented through the 95% confidence ellipsoid.</p> <p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">PC, principal component; PCoA, principal component analysis.</p>" ] ] 3 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0020" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Quantitative variables expressed as mean ± standard deviation. The <span class="elsevierStyleItalic">P</span> value refers to the comparison of 2 groups. Asterisks (*) indicate statistically significant results (<span class="elsevierStyleItalic">P</span> < .05).</p><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">BMI, body mass index; HbA1c, glycated haemoglobin; HDL, high-density lipoprotein; IGFBP-3, insulin-like growth factor binding protein 3; IGF-1, insulin-like growth factor 1; LDL, low-density lipoprotein.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Controls \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Cases before treatment \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Cases after 6 months of treatment \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">P</span>Cases vs controls \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">P</span>Cases before vs after treatment(paired) \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Number of patients \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">20 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">21 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">21 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">― \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">― \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Height (<span class="elsevierStyleItalic">z</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.14 ± 0.82 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">−2.37 ± 0.29 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">−2.08 ± 0.29 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.000* \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.000* \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Weight (<span class="elsevierStyleItalic">z</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">−0.52 ± 0.65 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">−1.45 ± 0.58 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">−1.40 ± 0.51 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.000* \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.122 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">BMI (kg/m<span class="elsevierStyleSup">2</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">15.7 ± 1.97 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">15.99 ± 3.02 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">16.26 ± 3.02 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.725 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.449 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">BMI (<span class="elsevierStyleItalic">z</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">−0.74 ± 0.62 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">−0.77 ± 0.83 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">−0.94 ± 0.67 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.890 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.054 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IGF-1 (ng/mL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">161.15 ± 77.75 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">157.76 ± 88.37 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">235.05 ± 108.21 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.897 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.000* \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IGF-1 (<span class="elsevierStyleItalic">z</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.29 ± 0.99 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">−0.39 ± 0.78 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.69 ± 0.73 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.019* \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.000* \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IGFBP-3 (mg/L) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4.54 ± 1.24 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4.79 ± 1.44 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5.21 ± 1.24 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.548 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.160 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Glucose (mg/dL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">86.40 ± 8.41 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">80.48 ± 7.61 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">88.62 ± 8.44 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.023* \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.001* \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Insulin (μU/mL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7.35 ± 4.84 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">9.85 ± 9.23 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">11.15 ± 5.63 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.362 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.436 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">HOMA index \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.23 ± 0.16 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.28 ± 0.26 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.35 ± 0.18 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.511 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.171 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">HbA1c (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5.18 ± 0.28 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5.09 ± 0.25 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5.12 ± 0.21 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.292 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.321 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Triglycerides (mg/dL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">60.10 ± 24.99 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">53.24 ± 16.84 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">66.71 ± 22.14 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.307 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.004* \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Total cholesterol (mg/dL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">166.75 ± 24.34 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">166.33 ± 26.95 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">160.05 ± 25.85 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.959 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.017* \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">HDL (mg/dL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">62.75 ± 15.27 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">66.33 ± 8.78 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">63.43 ± 12.34 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.360 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.150 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">LDL (mg/dL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">92.15 ± 24.30 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">89.57 ± 23.73 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">83.38 ± 19.90 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.733 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.034* \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3594073.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Comparison of controls and patients with growth hormone deficiency at baseline and after 6 months of treatment.</p>" ] ] 4 => array:5 [ "identificador" => "fig0020" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 826 "Ancho" => 1333 "Tamanyo" => 183365 ] ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:40 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Revised estimates for the number of human and bacteria cells in the body" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R. Sender" 1 => "S. Fuchs" 2 => "R. Milo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pbio.1002533" "Revista" => array:3 [ "tituloSerie" => "PLoS Biol" "fecha" => "2016" "volumen" => "14" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evolution of mammals and their gut microbes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.E. Ley" 1 => "M. Hamady" 2 => "C. Lozupone" 3 => "P.J. Turnbaugh" 4 => "R.R. Ramey" 5 => "J.S. Bircher" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.1155725" "Revista" => array:6 [ "tituloSerie" => "Science" "fecha" => "2008" "volumen" => "320" "paginaInicial" => "1647" "paginaFinal" => "1651" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18497261" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.B. DiGiulio" 1 => "R. Romero" 2 => "H.P. Amogan" 3 => "J.P. Kusanovic" 4 => "E.M. Bik" 5 => "F. Gotsch" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0003056" "Revista" => array:3 [ "tituloSerie" => "PLoS One" "fecha" => "2008" "volumen" => "3" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Meconium microbiome analysis identifies bacteria correlated with premature birth" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.N. Ardissone" 1 => "D.M. de la Cruz" 2 => "A.G. Davis-Richardson" 3 => "K.T. Rechcigl" 4 => "N. Li" 5 => "J.C. Drew" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0090784" "Revista" => array:3 [ "tituloSerie" => "PLoS One" "fecha" => "2014" "volumen" => "9" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Meconium microbiota types dominated by lactic acid or enteric bacteria are differentially associated with maternal eczema and respiratory problems in infants" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M.J. Gosalbes" 1 => "S. Llop" 2 => "Y. Vallès" 3 => "A. Moya" 4 => "F. Ballester" 5 => "M.P. Francino" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/cea.12063" "Revista" => array:6 [ "tituloSerie" => "Clin Exp Allergy" "fecha" => "2013" "volumen" => "43" "paginaInicial" => "198" "paginaFinal" => "211" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23331561" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dieta y microbiota. Impacto en la salud" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "G. Álvarez-Calatayud" 1 => "F. Guarner" 2 => "T. Requena" 3 => "A. Marcos" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.20960/nh.2280" "Revista" => array:6 [ "tituloSerie" => "Nutr Hosp" "fecha" => "2018" "volumen" => "35" "numero" => "N.º Extra. 6)" "paginaInicial" => "11" "paginaFinal" => "15" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The function of our microbiota: who is out there and what do they do?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "N. Ottman" 1 => "H. Smidt" 2 => "W.M. De Vos" 3 => "C. Belzer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fcimb.2012.00104" "Revista" => array:5 [ "tituloSerie" => "Front Cell Infect Microbiol" "fecha" => "2012" "volumen" => "2" "paginaInicial" => "104" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22919693" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microbiota, probióticos, prebióticos y simbióticos" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Hernández Hdez" 1 => "C. Coronel Rodríguez" 2 => "M. Monge Zamorano" 3 => "C. Quintana Herrera" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Pediatr Integral" "fecha" => "2015" "volumen" => "XIX" "paginaInicial" => "337" "paginaFinal" => "354" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microbiota en la salud humana: técnicas de caracterización y transferencia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R. Del Campo-Moreno" 1 => "T. Alarcón-Cavero" 2 => "G. DÀuria" 3 => "S. Delgado-Palacio" 4 => "M. Ferrer-Martínez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.eimc.2017.02.007" "Revista" => array:5 [ "tituloSerie" => "Enferm Infecc Microbiol Clin" "fecha" => "2018" "volumen" => "36" "paginaInicial" => "241" "paginaFinal" => "245" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gut microbiota: a key player in health and disease. A review focused on obesity" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.J. Villanueva-Millán" 1 => "P. Pérez-Matute" 2 => "J.A. Oteo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s13105-015-0390-3" "Revista" => array:6 [ "tituloSerie" => "J Physiol Biochem" "fecha" => "2015" "volumen" => "71" "paginaInicial" => "509" "paginaFinal" => "525" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25749935" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gut microbiota and host juvenile growth" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Schwarzer" 1 => "M. Strigini" 2 => "F. Leulier" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00223-017-0368-y" "Revista" => array:6 [ "tituloSerie" => "Calcif Tissue Int" "fecha" => "2018" "volumen" => "102" "paginaInicial" => "387" "paginaFinal" => "405" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29214457" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Schwarzer" 1 => "K. Makki" 2 => "G. Storelli" 3 => "I. Machuca-Gayet" 4 => "D. Srutkova" 5 => "P. Hermanova" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.aad8588" "Revista" => array:6 [ "tituloSerie" => "Science" "fecha" => "2016" "volumen" => "351" "paginaInicial" => "854" "paginaFinal" => "857" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26912894" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gut microbiota and IGF-1" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Yan" 1 => "J.F. Charles" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00223-018-0395-3" "Revista" => array:6 [ "tituloSerie" => "Calcif Tissue Int" "fecha" => "2018" "volumen" => "102" "paginaInicial" => "406" "paginaFinal" => "414" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29362822" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microbial and nutritional influence on endocrine control of growth" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F. De Vadder" 1 => "A. Joly" 2 => "F. Leulier" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1530/JME-20-0288" "Revista" => array:6 [ "tituloSerie" => "J Mol Endocrinol" "fecha" => "2021" "volumen" => "66" "paginaInicial" => "R67" "paginaFinal" => "R73" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33410764" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Crosstalk between the growth hormone/insulin-like growth factor-1 axis and the gut microbiome: a new frontier for microbial endocrinology" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E.A. Jensen" 1 => "J.A. Young" 2 => "S.C. Mathes" 3 => "E.O. List" 4 => "R.K. Carroll" 5 => "J. Kuhn" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ghir.2020.101333" "Revista" => array:4 [ "tituloSerie" => "Growth Horm IGF Res" "fecha" => "2020" "volumen" => "53–54" "paginaInicial" => "101333" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Characterization of an intestine-specific GH receptor knockout (IntGHRKO) mouse" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.A. Young" 1 => "E.A. Jensen" 2 => "A. Stevens" 3 => "S. Duran-Ortiz" 4 => "E.O. List" 5 => "D.E. Berryman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ghir.2019.05.001" "Revista" => array:6 [ "tituloSerie" => "Growth Horm IGF Res" "fecha" => "2019" "volumen" => "46-47" "paginaInicial" => "5" "paginaFinal" => "15" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31078722" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: lessons from mouse models" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S. Yakar" 1 => "O. Isaksson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ghir.2015.09.004" "Revista" => array:6 [ "tituloSerie" => "Growth Horm IGF Res" "fecha" => "2016" "volumen" => "28" "paginaInicial" => "26" "paginaFinal" => "42" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26432542" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Protective effects of growth hormone on bacterial translocation and intestinal damage in rats with partial intestinal obstruction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Kaymakci" 1 => "S. Guven" 2 => "I. Ciftci" 3 => "I. Akillioglu" 4 => "M. Aktan" 5 => "H.H. Eker" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4149/bll_2014_078" "Revista" => array:6 [ "tituloSerie" => "Bratisl Lek Listy" "fecha" => "2014" "volumen" => "115" "paginaInicial" => "395" "paginaFinal" => "399" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25077360" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lipid malabsorption from altered hormonal signaling changes early gut microbial responses" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "N.A. Terry" 1 => "L.V. Ngaba" 2 => "B.J. Wilkins" 3 => "D. Pi" 4 => "N. Gheewala" 5 => "K.H. Kaestner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1152/ajpgi.00135.2018" "Revista" => array:6 [ "tituloSerie" => "Am J Physiol Gastrointest Liver Physiol" "fecha" => "2018" "volumen" => "315" "paginaInicial" => "G580" "paginaFinal" => "G591" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29953253" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Manual de Diagnóstico y Terapéutica en Endocrinología Pediátrica" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J. Guerrero-Fdez" 1 => "I. González Casado" 2 => "N. Barreda Bonis" 3 => "N. Itza Martín" 4 => "C. Mora Palma" 5 => "L. Salamanca Fresno" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "2018" "paginaInicial" => "3" "paginaFinal" => "92" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of HIV infection and integrase strand transfer inhibitors-based treatment on the gut virome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Villoslada-Blanco" 1 => "P. Pérez-Matute" 2 => "M. Íñiguez" 3 => "E. Recio-Fernández" 4 => "D. Jansen" 5 => "L. De Coninck" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41598-022-25979-5" "Revista" => array:5 [ "tituloSerie" => "Sci Rep" "fecha" => "2022" "volumen" => "12" "paginaInicial" => "21658" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/36522388" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "R&D. Luminex Assay. [Accessed 8 Feb 2023]. Available from: <a target="_blank" href="https://www.rndsystems.com/resources/technical/luminex-assay-principle">https://www.rndsystems.com/resources/technical/luminex-assay-principle</a>." ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Integrase inhibitors partially restore bacterial translocation, inflammation and gut permeability induced by HIV infection: impact on gut microbiota" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Villoslada-Blanco" 1 => "P. Pérez-Matute" 2 => "M. Íñiguez" 3 => "E. Recio-Fernández" 4 => "P. Blanco-Navarrete" 5 => "L. Metola" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s40121-022-00654-4" "Revista" => array:6 [ "tituloSerie" => "Infect Dis Ther" "fecha" => "2022" "volumen" => "11" "paginaInicial" => "1541" "paginaFinal" => "1557" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/35618952" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "FastQC. [Accessed 8 Feb 2023]. Available from: <a target="_blank" href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</a>." ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Qiime2. Qiime2. [Accessed 16 Feb 2023]. Available from: <a target="_blank" href="https://qiime2.org/">https://qiime2.org/</a>." ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "DADA2: high-resolution sample inference from Illumina amplicon data" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "B.J. Callahan" 1 => "P.J. McMurdie" 2 => "M.J. Rosen" 3 => "A.W. Han" 4 => "A.J. Johnson" 5 => "SP Holmes" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nmeth.3869" "Revista" => array:6 [ "tituloSerie" => "Nat Methods" "fecha" => "2016" "volumen" => "13" "paginaInicial" => "581" "paginaFinal" => "583" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27214047" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "SILVA. [Accessed 16 Feb 2023]. Available from: <a target="_blank" href="https://www.arb-silva.de/">https://www.arb-silva.de/</a>." ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Analysis of composition of microbiomes: a novel method for studying microbial composition" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S. Mandal" 1 => "W. Van Treuren" 2 => "R.A. White" 3 => "M. Eggesbø" 4 => "R. Knight" 5 => "S.D. Peddada" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3402/mehd.v26.27663" "Revista" => array:5 [ "tituloSerie" => "Microb Ecol Health Dis" "fecha" => "2015" "volumen" => "26" "paginaInicial" => "27663" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26028277" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metabolic impacts of discontinuation and resumption of recombinant human growth hormone treatment during the transition period in patients with childhood-onset growth hormone deficiency" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y.J. Lee" 1 => "Y. Choi" 2 => "H.W. Yoo" 3 => "Y.A. Lee" 4 => "C.H. Shin" 5 => "H.S. Choi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3803/EnM.2021.1384" "Revista" => array:6 [ "tituloSerie" => "Endocrinol Metab (Seoul)" "fecha" => "2022" "volumen" => "37" "paginaInicial" => "359" "paginaFinal" => "368" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/35504604" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Glucose metabolism in children with growth hormone deficiency" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Ciresi" 1 => "C. Giordano" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fendo.2018.00321" "Revista" => array:5 [ "tituloSerie" => "Front Endocrinol (Lausanne)" "fecha" => "2018" "volumen" => "9" "paginaInicial" => "321" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29942285" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "T. Sas" 1 => "P. Mulder" 2 => "A. Hokken-Koelega" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jcem.85.10.6917" "Revista" => array:5 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2000" "volumen" => "85" "paginaInicial" => "3786" "paginaFinal" => "3792" ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0160" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effects of growth hormone treatment on lipid parameters" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Ü. Süleyman Ersin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.15761/CCRR.1000223" "Revista" => array:5 [ "tituloSerie" => "Clin Case Rep Rev" "fecha" => "2016" "volumen" => "2" "paginaInicial" => "383" "paginaFinal" => "386" ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0165" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Insulinlike growth factor 1 (IGF-1) reduces gut atrophy and bacterial translocation after severe burn injury" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "K.F. Huang" 1 => "D.H. Chung" 2 => "D.N. Herndon" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archsurg.1993.01420130051009" "Revista" => array:6 [ "tituloSerie" => "Arch Surg" "fecha" => "1993" "volumen" => "128" "paginaInicial" => "47" "paginaFinal" => "53" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8418780" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0170" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.X. Dong" 1 => "W. Zhao" 2 => "C. Solomon" 3 => "K.J. Rowland" 4 => "C. Ackerley" 5 => "S Robine" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/en.2013-1871" "Revista" => array:6 [ "tituloSerie" => "Endocrinology" "fecha" => "2014" "volumen" => "155" "paginaInicial" => "370" "paginaFinal" => "379" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24265452" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0175" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Short and long-term effects of growth hormone in children and adolescents with GH deficiency" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "MB Ranke" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fendo.2021.720419" "Revista" => array:5 [ "tituloSerie" => "Front Endocrinol (Lausanne)" "fecha" => "2021" "volumen" => "12" "paginaInicial" => "720419" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34539573" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0180" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Growth hormone reduces mortality and bacterial translocation in irradiated rats" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I.A. Gómez-de-Segura" 1 => "I. Prieto" 2 => "A.G. Grande" 3 => "P. García" 4 => "A. Guerra" 5 => "J. Mendez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/028418698429748" "Revista" => array:6 [ "tituloSerie" => "Acta Oncol" "fecha" => "1998" "volumen" => "37" "paginaInicial" => "179" "paginaFinal" => "185" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9636013" "web" => "Medline" ] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0185" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effect of recombinant human growth hormone (rhGH) on trinitrobenzene sulfonic acid-induced colitis in rats: an experimental study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "E. Kara" 1 => "H. Sungurtekin" 2 => "U. Sungurtekin" 3 => "M. Alkanat" 4 => "O. Ilkgul" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/00054725-200403000-00008" "Revista" => array:7 [ "tituloSerie" => "Inflamm Bowel Dis" "fecha" => "2004" "volumen" => "10" "numero" => "2" "paginaInicial" => "112" "paginaFinal" => "115" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15168810" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0190" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gut microbiota induce IGF-1 and promote bone formation and growth" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Yan" 1 => "J.W. Herzog" 2 => "K. Tsang" 3 => "C.A. Brennan" 4 => "M.A. Bower" 5 => "W.S. Garrett" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1073/pnas.1607235113" "Revista" => array:6 [ "tituloSerie" => "Proc Natl Acad Sci U S A" "fecha" => "2016" "volumen" => "113" "paginaInicial" => "E7554" "paginaFinal" => "E7563" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27821775" "web" => "Medline" ] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0195" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Growth hormone deficiency and excess alter the gut microbiome in adult male mice" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E.A. Jensen" 1 => "J.A. Young" 2 => "Z. Jackson" 3 => "J. Busken" 4 => "E.O. List" 5 => "R.K. Carroll" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/endocr/bqaa026" "Revista" => array:5 [ "tituloSerie" => "Endocrinology" "fecha" => "2020" "volumen" => "161" "paginaInicial" => "bqaa026" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32100023" "web" => "Medline" ] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0200" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Characteristics of gut microbiota in patients with GH-secreting pituitary adenoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B. Lin" 1 => "M. Wang" 2 => "R. Gao" 3 => "Z. Ye" 4 => "Y. Yu" 5 => "W. He" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/spectrum.00425-21" "Revista" => array:3 [ "tituloSerie" => "Microbiol Spectr" "fecha" => "2022" "volumen" => "10" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23412879/0000010000000006/v2_202407150516/S2341287924001431/v2_202407150516/en/main.assets" "Apartado" => array:4 [ "identificador" => "26005" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original Articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23412879/0000010000000006/v2_202407150516/S2341287924001431/v2_202407150516/en/main.pdf?idApp=UINPBA00005H&text.app=https://analesdepediatria.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287924001431?idApp=UINPBA00005H" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 October | 79 | 49 | 128 |
| 2024 September | 61 | 48 | 109 |
| 2024 August | 101 | 83 | 184 |
| 2024 July | 278 | 101 | 379 |
| 2024 June | 201 | 37 | 238 |
| 2024 May | 55 | 14 | 69 |
